Cargando…
Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories
Drug‐delivery systems (DDSs), in which drug encapsulation in nanoparticles enables targeted delivery of therapeutic agents and their release at specific disease sites, are important because they improve drug efficacy and help to decrease side effects. Although significant progress has been made in t...
Autores principales: | Nishimura, Tomoki, Akiyoshi, Kazunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247036/ https://www.ncbi.nlm.nih.gov/pubmed/30479925 http://dx.doi.org/10.1002/advs.201800801 |
Ejemplares similares
-
Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
por: Nishimura, Tomoki, et al.
Publicado: (2018) -
Magnetic Biotransport: Analysis and Applications
por: Furlani, Edward P.
Publicado: (2010) -
In situ Generation of Antibiotics using Bioorthogonal
“Nanofactories”
por: Li, Cheng-Hsuan, et al.
Publicado: (2021) -
Reaching New Biocatalytic Reactivity Using Continuous Flow Reactors
por: Cosgrove, Sebastian C., et al.
Publicado: (2022) -
Effectiveness Factors and Conversion in a Biocatalytic Membrane Reactor
por: Godongwana, Buntu
Publicado: (2016)